She tried to put up a fearless face by tweeting a somewhat philosophical comment, insisting that "no words, games or actions will ever stop me from reaching my own dreams". "And I have many", Sharapova wrote on Twitter following her snub.
The FFT said it would be wrong to give a wildcard to a player whose failure to qualify for next week's tournament owed to a doping suspension rather than injury. "But it didn't seem possible for me to go above the strong commitment and the respect for the anti-doping code". "I fully support the players that received wildcards and wish them the very best of luck".
"She might be very disappointed, but it's my responsibility, it's my mission to protect the game and protect the high standards of the game", he said.
She recently returned to the tour after serving a 15-month doping ban.
The Russian, a two-time champion at Roland Garros, was informed that her request for entry into the forthcoming grand slam following her recent return from a drugs ban had been rejected on Tuesday.
The decision also drew ire from Steve Simon, the head of the Women's Tennis Association, who vehemently disagreed with the FTF and said Sharpapova "compiled with the sanction imposed". "We can not decide, on the one hand, to increase the amount of funds we dedicate to the anti-doping battle and, on the other, invite her", he said in March.
For Bernard Giudicelli, the fight against doping was more important than Maria Sharapova's popularity.
"She needs to take a step back and reconcile that her return to major tennis is going to have to wait and not be bitter about it".
"The Tennis Anti-Doping Programme (TADP) is a uniform effort supported by the Grand Slams, WTA, ITF and ATP".
Wimbledon, in contrast to the French Open, is likely to have the luxury of knowing that even without offering Sharapova a wild card there is every chance that she will play at the All England Club this summer by winning three matches in the qualifying competition.
The Russian issued a statement afterward that failed to address the French Open and said merely that she hoped her injury "is not serious".
Sharapova tested positive for heart disease drug meldonium at last year's Australian Open.
But the French Tennis Federation (FFT) took the unexpected decision on Tuesday to refuse her entry.
Sharapova, whose ranking has plummeted to 211 leaving her reliant on wildcards, could have earned her spot at Wimbledon by reaching the semi-finals in Italy but retired against Mirjana Lucic-Baroni in the final set with a thigh injury.
Sharapova's return has been rocky and several leading players have criticized tournament directors at WTA events in Stuttgart, Madrid and Rome for offering her a wild card, arguing that she should be awarded no special treatment.